Furthermore, Wang et al. [71] showed that CD73 expression increased during B-cell maturation, whereas expression of CD73 was higher in common- and pre-B-ALL compared with pro-B-ALL patients, and the expression was stable during treatment [70,71]. This evidence concerns the gene NT5E and acute lymphoblastic leukemia.